That declaration of failed PFS based on faulty measure criteria may have worked on a bunch of nervous investors helped into their fear by market makers willing to prey on that back on May 10th 2022 but repeating it now just magnifies your insincerity and reason for you and others claiming the same and other negative rants being here now. So would you like to answer for Investor082 why the two of you are here ignoring the obvious to focus on the past?; ). Why are you here?; ). Best wishes.
That wasn’t the road I hoped you go down. Sure the Plll was a mess but that doesn’t mean DCVAX doesn’t work. I’m looking for specifics on why NK’s might work for GBM as compared to DC’s specifically between the two trials? Or perhaps it’s just more about getting the lymph count back up?
Market Data 
Markets 
AI
